Warning: The NCBI web site requires JavaScript to function. more...
Nebulized antithrombin limits bacterial outgrowth and lung injury in Streptococcus pneumoniae pneumonia in rats.
Hofstra JJ, Cornet AD, de Rooy BF, Vlaar AP, van der Poll T, Levi M, Zaat SA, Schultz MJ.
Crit Care. 2009;13(5):R145. Epub 2009 Sep 9.
Related citations
Antithrombin inhibits bronchoalveolar activation of coagulation and limits lung injury during Streptococcus pneumoniae pneumonia in rats.
Choi G, Hofstra JJ, Roelofs JJ, Rijneveld AW, Bresser P, van der Zee JS, Florquin S, van der Poll T, Levi M, Schultz MJ.
Crit Care Med. 2008 Jan;36(1):204-10.
Ventilator-induced coagulopathy in experimental Streptococcus pneumoniae pneumonia.
Haitsma JJ, Schultz MJ, Hofstra JJ, Kuiper JW, Juco J, Vaschetto R, Levi M, Zhang H, Slutsky AS.
Eur Respir J. 2008 Dec;32(6):1599-606. Epub 2008 Sep 3.
Nebulized anticoagulants limit pulmonary coagulopathy, but not inflammation, in a model of experimental lung injury.
Hofstra JJ, Vlaar AP, Cornet AD, Dixon B, Roelofs JJ, Choi G, van der Poll T, Levi M, Schultz MJ.
J Aerosol Med Pulm Drug Deliv. 2010 Apr;23(2):105-11.
Nebulized anticoagulants limit coagulopathy but not inflammation in pseudomonas aeruginosa-induced pneumonia in rats.
Cornet AD, Hofstra JJ, Vlaar AP, van den Boogaard FE, Roelofs JJ, van der Poll T, Levi M, Groeneveld AB, Schultz MJ.
Shock. 2011 Oct;36(4):417-23.
Inhibition of coagulation and inflammation by activated protein C or antithrombin reduces intestinal ischemia/reperfusion injury in rats.
Schoots IG, Levi M, van Vliet AK, Maas AM, Roossink EH, van Gulik TM.
Crit Care Med. 2004 Jun;32(6):1375-83.
Natural anticoagulants limit lipopolysaccharide-induced pulmonary coagulation but not inflammation.
Choi G, Vlaar AP, Schouten M, Van't Veer C, van der Poll T, Levi M, Schultz MJ.
Eur Respir J. 2007 Sep;30(3):423-8. Epub 2007 May 30.
Plasma-Derived Human Antithrombin Attenuates Ventilator-Induced Coagulopathy but not Inflammation in a Streptococcus pneumoniae Pneumonia Model in Rats.
Aslami H, Haitsma JJ, Hofstra JJ, Florquin S, Dos Santos C, Streutker C, Zhang H, Levi M, Slutsky AS, Schultz MJ.
J Thromb Haemost. 2012 Jan 11. doi: 10.1111/j.1538-7836.2012.04622.x. [Epub ahead of print]
Recombinant human activated protein C inhibits local and systemic activation of coagulation without influencing inflammation during Pseudomonas aeruginosa pneumonia in rats.
Choi G, Hofstra JJ, Roelofs JJ, Florquin S, Bresser P, Levi M, van der Poll T, Schultz MJ.
Crit Care Med. 2007 May;35(5):1362-8.
The thiazolidinedione ciglitazone reduces bacterial outgrowth and early inflammation during Streptococcus pneumoniae pneumonia in mice.
Stegenga ME, Florquin S, de Vos AF, van der Poll T.
Crit Care Med. 2009 Feb;37(2):614-8.
Effects of anticoagulant strategies on activation of inflammation and coagulation.
Feistritzer C, Wiedermann CJ.
Expert Opin Biol Ther. 2007 Jun;7(6):855-70. Review.
Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.
Idell S.
Crit Care Med. 2003 Apr;31(4 Suppl):S213-20. Review.
Protective effects of antithrombin on puromycin aminonucleoside nephrosis in rats.
Yamashita J, Nakajima K, Ohno Y, Kaneshiro Y, Matsuo T, Tanaka H, Kaneko K.
Eur J Pharmacol. 2008 Jul 28;589(1-3):239-44. Epub 2008 May 14.
Anticoagulant and anti-inflammatory effects after peritoneal lavage with antithrombin in experimental polymicrobial peritonitis.
van Veen SQ, Cheung CW, Meijers JC, van Gulik TM, Boermeester MA.
J Thromb Haemost. 2006 Nov;4(11):2343-51. Epub 2006 Aug 15.
Final Report on Carcinogens Background Document for Styrene.
National Toxicology Program.
Rep Carcinog Backgr Doc. 2008 Sep;(8-5978):i-398.
[Total hepatic ischemia-reperfusion-induced lung injury in rats and protective effects of melatonin].
Jiang CL, Yang BX, Zhao D, Jia R.
Beijing Da Xue Xue Bao. 2008 Jun 18;40(3):285-91. Chinese.
Combined anticoagulants ameliorate acute lung injury in sheep after burn and smoke inhalation.
Enkhbaatar P, Esechie A, Wang J, Cox RA, Nakano Y, Hamahata A, Lange M, Traber LD, Prough DS, Herndon DN, Traber DL.
Clin Sci (Lond). 2008 Feb;114(4):321-9.
Current view on alveolar coagulation and fibrinolysis in acute inflammatory and chronic interstitial lung diseases.
Wygrecka M, Jablonska E, Guenther A, Preissner KT, Markart P.
Thromb Haemost. 2008 Mar;99(3):494-501. Review.
Role of coagulation inhibitors in inflammation.
Esmon CT.
Thromb Haemost. 2001 Jul;86(1):51-6. Review.
The role of bronchoalveolar hemostasis in the pathogenesis of acute lung injury.
Hofstra JJ, Haitsma JJ, Juffermans NP, Levi M, Schultz MJ.
Semin Thromb Hemost. 2008 Jul;34(5):475-84. Epub 2008 Oct 27. Review.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on